Cancer Research UK announces clinical trial for most common type of lung cancer
News
First-of-its-kind NHS gene pilot takes off
The NHS launches world-first study investigating genetic testing for common diseases
CDI prevention reaches date with destiny
Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead
Poolbeg Pharma dives into nasally administered antivirals
If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at
Gates Foundation supports HIV and malaria research
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation
While Omicron continues to dominate across the world, COVID-19 travel requirements remain
Djokovic drama causes a racket: so how would the UK respond?
Collaborative research approach set to accelerate treatment of Alport syndrome
Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required.
New study finds AstraZeneca booster generates higher antibodies against Omicron
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.
Liverpool CCG and Community Pharmacy Liverpool launch FebriDx point-of-care test
The test is hoped to provide patients with a more convenient means of access to treatment for respiratory issues.
UKHSA estimates one in seven still infectious after five day COVID-19 isolation
Under current guidelines, individuals that test positive for COVID-19 may be able to leave self-isolation after 7 days if certain conditions are met.
Oxford joins consortium to advance quantum drug discovery
The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
European Commission approves cystic fibrosis treatment for six to 11-year-olds
There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK currently diagnosed with the disease.
Pregnant women urged to receive COVID-19 booster amid surging cases
Since April 2021, around 84,000 pregnant women have received at least one COVID-19 vaccination.
The NICE recommends Rinvoq for psoriatic arthritis patients
The chronic, inflammatory disease affects an estimated 24 in every 10,000 people.
NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer
With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.
